Nebenwirkungen · Insuman
Insuman Comb 25 40 IU/ml suspension for injection in a vial Insuman Comb 25 100 IU/ml suspension for injection in a vial Insuman Comb 25 100 IU/ml suspension for injection in a cartridge Insuman Comb 25 SoloStar 100 IU/ml suspension for injection in a pre-filled pen · Abschnitt 4.8 · PDF-Seite 52
HOS-088677 · Präparat HOS-083671
MedDRA system Common Uncommon Not known organ classes Immune system Shock Immediate type disorders allergic reactions (hypotension, angioneurotic oedema, bronchospasm, generalised skin reactions); Anti-insulin antibodies Metabolism and Oedema Hypoglycaemia; nutrition disorders Sodium retention Eye disorders Proliferative retinopathy; Diabetic retinopathy; Visual impairment Skin and Lipodystrophy; subcutaneous tissue Cutaneous amyloidosis disorders General disorders Injection site reactions Injection site urticaria Injection site and administration inflammation; site conditions Injection site pain; Injection site pruritus; Injection site erythema; Injection site swelling
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-03-05T14:48:00Z · SHA-256 361eee512a62ae9d440e9dc3368e92bfdf642f50b791ed122087c5b884c15e02 · Passage e9a743d850129609bab878e31e9999bf52fbb1a8ed2ba826a959f487fad90b3e · Zeichen 827–3202 im Abschnitt